Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory (2018 - 2025)

Agios Pharmaceuticals' Inventory history spans 7 years, with the latest figure at $32.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 19.21% year-over-year to $32.9 million; the TTM value through Dec 2025 reached $32.9 million, up 19.21%, while the annual FY2025 figure was $32.9 million, 19.21% up from the prior year.
  • Inventory reached $32.9 million in Q4 2025 per AGIO's latest filing, up from $32.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $32.9 million in Q4 2025 to a low of $2.5 million in Q1 2022.
  • Average Inventory over 4 years is $19.4 million, with a median of $21.1 million recorded in 2023.
  • Peak YoY movement for Inventory: surged 357.71% in 2023, then grew 19.21% in 2025.
  • A 4-year view of Inventory shows it stood at $8.5 million in 2022, then soared by 124.63% to $19.1 million in 2023, then skyrocketed by 44.77% to $27.6 million in 2024, then rose by 19.21% to $32.9 million in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Inventory are $32.9 million (Q4 2025), $32.0 million (Q3 2025), and $30.8 million (Q2 2025).